Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration this week issued an emergency use authorization for Siemens Healthcare Diagnostics' Advia Centaur Zika test.

The EUA was issued for the test for the qualitative detection of Zika virus IgM antibodies in human serum and plasma collected from individuals who meet the Zika virus clinical criteria of the US Centers for Disease Control and Prevention, and/or CDC's Zika virus epidemiological criteria, the FDA said. The authorization also is for the test to be done in CLIA-certified laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.